FLX475

DB15570InvestigationalSmall molecule

FLX475 is a small molecule CCR4 antagonist being investigated for the treatment of cancer.

Code names
FLX-475

Resolves to

Compound
UNIIR1T69T65FJ
Targets
P51679CCR4

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with FLX475, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In